Showing results (51-60 of 389) with videos related to

Sort By:
Pageof 39
International Journal of Clinical Oncology|June 15, 2007
Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experienceToshio Shimizu, Taroh Satoh, Kenji Tamura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterationsJunko Tanizaki, Isamu Okamoto, Kunio Okamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patientsSatoshi Anai, Eiji Iwama, Yasuto Yoneshima, et al.
Respiratory Investigation|February 27, 2024
Osimertinib readministration for central nervous system metastases in non-small cell lung cancer positive for EGFR activating mutationsYu Inutsuka, Eiji Iwama, Yoshimasa Shiraishi, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2003
Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancerIsamu Okamoto, Kazuhiko Fujii, Mitsuhiro Matsumoto, et al.
Cancer Letters|September 9, 2006
Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G(2)-M arrest in A549 cellsMasato Ikeda, Isamu Okamoto, Kenji Tamura, et al.
Cancer Research|July 30, 2009
Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cellsKen Takezawa, Isamu Okamoto, Kimio Yonesaka, et al.
International Journal of Clinical Oncology|March 13, 2010
Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexedHidetoshi Hayashi, Isamu Okamoto, Yasuko Ichikawa, et al.
NPJ Precision Oncology|March 2, 2024
TP53 gain-of-function mutations promote osimertinib resistance via TNF-α-NF-κB signaling in EGFR-mutated lung cancerRitsu Ibusuki, Eiji Iwama, Atsushi Shimauchi, et al.
Clinical Lung Cancer|February 15, 2024
A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial)Atsushi Kamigaichi, Akira Hamada, Masahiro Tsuboi, et al.
Pageof 39